Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 25-Apr-2014
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 22)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
24-Apr-14ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for ACT11$25  View Abstract
24-Apr-14ValuEngine, Inc.N/AValuEngine Industry Report for Medical-generic Drugs17$49  View Abstract
23-Apr-14Thomson Reuters Stock ReportN/AThomson Reuters Stock Report - ACTIVE CONTROL TECHNOLOGY INC. (ACT-V)9$25  View Abstract
19-Apr-14S&P Capital IQ – STARS ReportsN/AActavis Plc11$126.50  View Abstract
19-Apr-14Reuters Investment ProfileN/AAction SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138  View Abstract
19-Apr-14Reuters Investment ProfileN/AActive Control Technology Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138  View Abstract
17-Apr-14ValuEngine, Inc.N/AValuEngine - Toronto Quantitative Stock Report for ACT11$25  View Abstract
17-Apr-14Ford Investor Services, Inc.N/AValue Graph: ACTAVIS PLC -- ACT1$11.50  View Abstract
17-Apr-14Ford Investor Services, Inc.N/AIndustry Value Graph: ACT , AGN , FRX , NVO , SHPG -- DRUGS3$34.50  View Abstract
13-Apr-14TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: ACTAVIS PLC (ACT)5$10  View Abstract
Next 12

Independent Reports (Showing 1 to 10 of 22)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
24-Apr-14ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for ACT11$25View Abstract
24-Apr-14ValuEngine, Inc.N/AValuEngine Industry Report for Medical-generic Drugs17$49View Abstract
23-Apr-14Thomson Reuters Stock ReportN/AThomson Reuters Stock Report - ACTIVE CONTROL TECHNOLOGY INC. (ACT-V)9$25View Abstract
19-Apr-14S&P Capital IQ – STARS ReportsN/AActavis Plc11$126.50View Abstract
19-Apr-14Reuters Investment ProfileN/AAction SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138View Abstract
19-Apr-14Reuters Investment ProfileN/AActive Control Technology Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138View Abstract
17-Apr-14ValuEngine, Inc.N/AValuEngine - Toronto Quantitative Stock Report for ACT11$25View Abstract
17-Apr-14Ford Investor Services, Inc.N/AValue Graph: ACTAVIS PLC -- ACT1$11.50View Abstract
17-Apr-14Ford Investor Services, Inc.N/AIndustry Value Graph: ACT , AGN , FRX , NVO , SHPG -- DRUGS3$34.50View Abstract
13-Apr-14TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: ACTAVIS PLC (ACT)5$10View Abstract
Next 12

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.